Important Safety Information

Effective Date: July 7, 2026

The information below summarizes important safety information for treatments available through MedReadyMD Inc. It is not a complete list of risks, warnings, or side effects, and it is not medical advice. Your licensed healthcare provider will review your health history and determine whether a treatment is appropriate for you. Always follow your provider's instructions and read the materials dispensed with your medication. If you are experiencing a medical emergency, call 911 or go to your nearest emergency department.

About compounded medications: Some medications available through MedReadyMD are compounded by state-licensed compounding pharmacies pursuant to a prescription from a licensed healthcare provider. Compounded medications are permitted under federal law but are not FDA-approved and are not evaluated by the FDA for safety, effectiveness, or quality. FDA-approved medications containing the same or similar active ingredients may be available. Talk to your provider about all of your treatment options.

Reporting side effects: Contact your provider through your patient portal, email support@medreadymd.com, or report directly to FDA MedWatch at 1-800-FDA-1088 or fda.gov/medwatch.

GLP-1 Medications (Compounded Semaglutide, Compounded Tirzepatide)

WARNING — RISK OF THYROID C-CELL TUMORS: In rodent studies, GLP-1 receptor agonists caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC). It is not known whether these medications cause thyroid C-cell tumors in humans.

Do not use GLP-1 medications if you:

  • Have a personal or family history of medullary thyroid carcinoma (MTC)
  • Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Have had a serious allergic reaction to the medication or any of its ingredients
  • Are pregnant, breastfeeding, or planning to become pregnant (discontinue at least 2 months before a planned pregnancy)

Warnings and precautions:

  • Pancreatitis: Stop use and seek medical care immediately for severe abdominal or back pain that will not go away, with or without vomiting.
  • Gallbladder problems: including gallstones; symptoms include pain in the upper abdomen, fever, yellowing of skin or eyes, or clay-colored stools.
  • Kidney injury: nausea, vomiting, or diarrhea can cause dehydration, which may worsen kidney function.
  • Low blood sugar (hypoglycemia): risk is higher if you also take insulin or a sulfonylurea.
  • Vision changes: tell your provider if you have diabetes and notice vision changes (diabetic retinopathy).
  • Severe gastrointestinal disease: these medications slow stomach emptying and may not be appropriate if you have severe GI disease; delayed stomach emptying can also affect absorption of oral medications.
  • Surgery and anesthesia: tell all of your healthcare providers you take a GLP-1 medication before any surgery or procedure requiring anesthesia or deep sedation.
  • Mental health: tell your provider about any history of depression or suicidal thoughts, and seek help immediately if you experience new or worsening mood symptoms.
  • Thyroid symptoms: tell your provider immediately about any lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath.

Most common side effects: nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, indigestion, headache, fatigue, dizziness, and injection-site reactions.

NAD+ (Nicotinamide Adenine Dinucleotide)

NAD+ is not FDA-approved for any medical indication, and its long-term safety and effectiveness have not been established in large-scale clinical trials. NAD+ preparations available through MedReadyMD are compounded and are not evaluated by the FDA for safety, effectiveness, or quality.

  • Do not use if: you are pregnant or breastfeeding, or have had an allergic reaction to NAD+ preparations.
  • Common side effects: injection-site redness or discomfort, flushing, nausea, headache, and fatigue. Rapid administration may cause chest pressure or cramping.

Sermorelin

Sermorelin is a growth hormone-releasing hormone (GHRH) analog. Its effectiveness for wellness, recovery, or anti-aging purposes has not been established in large-scale clinical trials, and compounded sermorelin is not FDA-approved.

  • Do not use if: you have an active malignancy (cancer), or a known allergy to sermorelin. Tell your provider about any history of cancer before starting treatment.
  • Common side effects: injection-site reactions (pain, redness, swelling), flushing, headache, dizziness, and drowsiness.

Glutathione

Glutathione is an antioxidant. Its effectiveness for most wellness uses has not been established in large-scale clinical trials, and compounded glutathione is not FDA-approved.

  • Do not use if: you are pregnant or breastfeeding without provider guidance, or have had an allergic reaction to glutathione.
  • Common side effects: injection-site reactions, abdominal cramping, or bloating. People with asthma should use caution, as glutathione may trigger bronchospasm in some individuals.

Sildenafil and Tadalafil

Sildenafil and tadalafil are FDA-approved medications for erectile dysfunction (the FDA-approved products; any compounded formulations are not FDA-approved). They require a prescription from a licensed provider.

Do not use if you:

  • Take nitrates in any form (such as nitroglycerin) — the combination can cause an unsafe drop in blood pressure that may be life-threatening
  • Take riociguat (Adempas®)
  • Have been advised by a provider not to have sexual activity because of heart problems
  • Have had a serious allergic reaction to the medication

Warnings and precautions:

  • Cardiovascular: tell your provider about any heart disease, recent heart attack or stroke, uncontrolled blood pressure (high or low), or heart rhythm problems.
  • Alpha-blockers and blood pressure medications: may interact and cause low blood pressure; tell your provider about all medications you take.
  • Priapism: seek immediate medical care for an erection lasting longer than 4 hours — permanent damage can result.
  • Vision or hearing changes: stop use and seek medical care for sudden vision loss in one or both eyes or sudden decrease or loss of hearing.

Most common side effects: headache, flushing, nasal congestion, indigestion, dizziness, back pain and muscle aches (more common with tadalafil), and temporary vision color changes (more common with sildenafil).

Minoxidil / Finasteride (Hair Loss Treatment)

Finasteride:

  • Not for use by women. Women who are pregnant or may become pregnant must not take finasteride or handle crushed or broken tablets — exposure can cause abnormalities of the external genitalia of a male fetus.
  • Possible side effects: decreased libido, erectile dysfunction, decreased ejaculate volume, breast tenderness or enlargement, and mood changes including depression; in some men, sexual side effects have continued after stopping treatment. Report any breast lumps, pain, nipple discharge, or mood changes to your provider promptly.
  • Finasteride can affect PSA (prostate cancer screening) test results — tell any provider ordering a PSA test that you take finasteride.

Minoxidil (topical):

  • Possible side effects: scalp irritation, itching, dryness or flaking, unwanted facial hair growth if the product spreads, and temporary increased shedding during the first weeks of use.
  • Stop use and contact a provider if you experience chest pain, rapid heartbeat, faintness, dizziness, sudden unexplained weight gain, or swelling of the hands or feet.

Individual results vary. No outcome is guaranteed. Prescriptions are issued only when a licensed healthcare provider determines treatment is medically appropriate. This page is provided for informational purposes and does not replace the prescribing information dispensed with your medication or the advice of your provider.